Related Experiment Video
Updated: Aug 8, 2026
10:24
Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.1K
Autologous Pericranium Graft for Necrotizing Scleritis
Sergio Copete1, María Antonia Fagúndez-Vargas1, Franciso López-Martínez1
1Ophthalmology Department, Albacete University Hospital Complex, Albacete, Spain; and.
Cornea
|July 30, 2024
Summary
Autologous pericranium grafting successfully treated scleral staphyloma secondary to necrotizing scleritis after a previous graft failure. This approach offers a viable alternative for managing scleral thinning in complex cases.
Area of Science:
- Ophthalmology
- Surgical Innovation
Background:
- Necrotizing scleritis can lead to scleral thinning and staphyloma formation.
- Previous treatments, including homologous scleral grafting, may fail in managing these complex ocular conditions.
Observation:
- A case report details a 63-year-old woman with necrotizing scleritis and choroidal protrusion.
- Initial homologous scleral grafting failed; subsequent treatment involved autologous pericranium grafting.
Findings:
- A 3x2 cm autologous pericranium patch was grafted to the staphyloma borders.
- Complete re-epithelialization occurred within 3 weeks, with successful graft integration.
- No signs of inflammation were observed at an 18-month follow-up.
Implications:
- Autologous pericranium grafting is a viable alternative for treating scleral thinning caused by necrotizing scleritis.
- This technique may offer a durable solution for complex scleral defects where other methods have failed.
